Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Constantine S. Tam, MBBS, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, Gareth P Gregory, MBBS (Hons), PhD FRACP, FRCPA, Aichun Liu, MD, Anna M. Johnston, Weili Zhao, MD PhD, Fernando Roncolato, BMed, FRACP, FRCPA, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS (Hons), MD FRACP, FRCPA, AFRCMA, MACD, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Wenyu Li, MD PhD, Ted Shih, PharmD, Xiaoping Zhang, MD MS, Ken Wu, PhD, Yuan Liu, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA

Blood (2019) 134 (Supplement_1): 1594.

https://doi.org/10.1182/blood-2019-125485

Published: 2019

Journal Articles

Carbapenemase-Producing Enterobacteriaceae (CPE) Bloodstream Infections (BSI) in Neutropenic Patients (pts) with Acute Leukemia (AL). Comparison of 2 Strategies

Marcos Lemos, MD, Rebeca Brito, MD, Margarida Fevereiro, MD, Mariana L. Fernandes, MD, Filipa Saraiva, MD, Susana G Pereira, MD, Leonor Sarmento, MD, Alexandra Monteiro, MD, Aida B Sousa, MD

Blood (2019) 134 (Supplement_1): 1333.

https://doi.org/10.1182/blood-2019-124986

Published: 2019

Journal Articles

Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in Dyskeratosis Congenita

Christopher Lengner

Blood (2018) 132 (Supplement 1): SCI-30.

https://doi.org/10.1182/blood-2018-99-109480

Published: 2018

Journal Articles

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Shona Philip, BSc, MSc, MD, Christopher Bredeson, MD FRCPC, MSc, David S. Allan, MD FRCPC, MSc, Sultan Altouri, MD FRCPC, Lothar B. Huebsch, MD, Harold Atkins, MD, Natasha Kekre, MD FRCPC

Blood (2018) 132 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2018-99-119797

Published: 2018

Journal Articles

Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis

Marta Davidson, MDPhD, Douglas A. Stewart, Peter Duggan, MD FRCPC, Andrew Daly, MD, Mona Shafey, MD

Blood (2017) 130 (Supplement 1): 4534.

https://doi.org/10.1182/blood.V130.Suppl_1.4534.4534

Published: 2017

Journal Articles

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

David Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, David A. Weinstein, MD MMSc, Cornelia Zeidler, Karl Welte

Blood (2017) 130 (Supplement 1): 996.

https://doi.org/10.1182/blood.V130.Suppl_1.996.996

Published: 2017

Journal Articles

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Guillermo Martín-Sánchez, MD, Cristina Amunarriz, MD, Miriam Sanchez, Maria Aranzazu Bermudez, MD, Lucrecia Yañez, MD PhD, Mercedes Colorado, MD, Carlos Richard, MD, Eulogio Conde, MD PhD, Jose Luis Arroyo, MD PhD

Blood (2016) 128 (22): 5737.

https://doi.org/10.1182/blood.V128.22.5737.5737

Published: 2016

Journal Articles

Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study)

Hideki Nakasone, MD/PhD, Kiriko Terasako-Saito, Teiichi Hirano, MD, Atsushi Wake, MD PhD, Seiichi Shimizu, MD PhD, Etsuko Yamazaki, MD PhD, Kouhei Akazawa, Kensuke Usuki, MD PhD, Shigeru Chiba, MD, PhD, Koichiro Minauchi, MD, Etsuo Miyaoka, Shuichi Ota, MD, Shuichi Taniguchi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2016) 128 (22): 3463.

https://doi.org/10.1182/blood.V128.22.3463.3463

Published: 2016

Journal Articles

Myeloma Canada Research Network (MCRN)-001 ASCT Study of Busulfan + Melphalan (BuMel) Conditioning Followed By Lenalidomide (Len) Maintenance: Updated Results Including Serial Minimal Residual Disease (MRD) and Involved Serum Hevylite™ Chain (HLC) Ratio Assessments

Donna Reece, MD, Giovanni Piza Rodriguez, MD, Mariela Pantoja, PhD MSc, Darrell White, MD, Christopher P. Venner, MD, Julie Stakiw, MD, Michael Sebag, MD PhD, Terrance Comeau, MD, Kevin W. Song, MD, Jean Roy, MD, Martha L Louzada, MD, Arleigh McCurdy, MD, Vishal Kukreti, MD, Suzanne Trudel, MD, Anca Prica, MD, Rodger Tiedemann, MBChB, PhD, Christine Chen, MD, Harminder Paul, BSc

Blood (2016) 128 (22): 4632.

https://doi.org/10.1182/blood.V128.22.4632.4632

Published: 2016

Journal Articles

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Maria Luisa Sulis, MD, Traci M. Blonquist, MS, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter D. Cole, MD, Kara M. Kelly, MD, Caroline Laverdiere, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Donna S Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 249.

https://doi.org/10.1182/blood.V126.23.249.249

Published: 2015

Journal Articles

Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities

Benjamin L Lampson, MD PhD, Tiago Matos, MD MSc, Haesook T. Kim, PhD, Siddha Kasar, PhD, Elizabeth A. Morgan, MD, Masahiro Hirakawa, MD PhD, Joshua Fein, Stacey M. Fernandes, Jerome Ritz, MD, Jennifer R. Brown, MD PhD

Blood (2015) 126 (23): 497.

https://doi.org/10.1182/blood.V126.23.497.497

Published: 2015

Journal Articles

Extrahematopoietic Manifestations of Telomere Syndromes

Mary Armanios, MD

Blood (2015) 126 (23): SCI-51.

https://doi.org/10.1182/blood.V126.23.SCI-51.SCI-51

Published: 2015

Journal Articles

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Amanda N Seddon, PharmD, Angela G Michael, PharmD, BCOP, Nelly G. Adel, PharmD, BCOP, BCPS, Martin S. Tallman, MD, Oguz Akin, MD, Joshua Chaim, MD, Esther Drill, MS

Blood (2014) 124 (21): 3725.

https://doi.org/10.1182/blood.V124.21.3725.3725

Published: 2014

Journal Articles

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Merideth L. Kelley, MS, BS, Lan Phan, BA, Laurence A. Boxer, MD, Priya S. Kishnani, MD, MB, Joanne Kurtzberg, MD, David A. Weinstein, MD, MMSc

Blood (2013) 122 (21): 2265.

https://doi.org/10.1182/blood.V122.21.2265.2265

Published: 2013

Journal Articles

G6PC3 Deficiency Associated with Congenital Neutropenia and Enterocolitis

Jana Diestelhorst, Daniel Kotlarz, Giridharan Appaswamy, PhD, Rita Beier, MD, Peter M Krawitz, MD, PhD, Peter N Robinson, MD, PhD, Jochen Hecht, PhD, Jacek Puchalka, PhD, Alejandro A. Schäffer, PhD, Dietmar Pfeifer, PhD, Ulrich Baumann, MD, Eva-Doreen Pfister, MD, Gudrun Brandes, PhD, Gabriella Palla, MD, Roland Jacobs, PhD, Hans H. Kreipe, MD, Stefan Mundlos, MD, Christoph Klein, MD, PhD

Blood (2011) 118 (21): 2170.

https://doi.org/10.1182/blood.V118.21.2170.2170

Published: 2011

Journal Articles

Initial Findings From the PACE Trial: A Pivotal Phase 2 Study of Ponatinib in Patients with CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or with the T315I Mutation

Blood (2011) 118 (21): 109.

https://doi.org/10.1182/blood.V118.21.109.109

Published: 2011

Journal Articles

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Kenshi Suzuki, MD, PhD, Kiyoshi Ando, MD, PhD, Akira Sakai, MD, PhD, Shinsuke Iida, MD, PhD, Michinori Ogura, Kensei Tobinai, MD, PhD, Morio Matsumoto, MD, Kosei Matsue, MD, PhD, Yasuhito Terui, MD, PhD, Kazuteru Ohashi, MD, Takaaki Chou, MD, PhD, Kazutaka Sunami, MD, PhD, Atsushi Shinagawa, MD, Nobuyuki Aotsuka, MD, PhD, Hirohiko Shibayama, MD, PhD, Takayuki Takahashi, MD, PhD, Harumi Yamamoto Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD

Blood (2011) 118 (21): 5132.

https://doi.org/10.1182/blood.V118.21.5132.5132

Published: 2011

Journal Articles

Neutropenia in Glycogen Storage Disease 1b (GSD1b)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Lan Phan, BA, Laurence A. Boxer, MD, Priya S. Kishnani, Joanne Kurtzberg, MD, David A. Weinstein

Blood (2011) 118 (21): 4791.

https://doi.org/10.1182/blood.V118.21.4791.4791

Published: 2011

Journal Articles

Clinical Usefulness of Procalcitonin in Hematopoietic Stem Cell Transplantation

Junji Koya, Yasuhito Nannya, MD, Motoshi Ichikawa, Mineo Kurokawa, MD

Blood (2011) 118 (21): 4560.

https://doi.org/10.1182/blood.V118.21.4560.4560

Published: 2011

Journal Articles

Protective Effect of Rituximab Against Lymphoma Risk In HIV-Associated Multicentric Castleman Disease

Jean Marie Michot, Laurence Gérard, MD, Claire Fieschi, PhD, Sarah Burcheri, MD, Eric Oksenhendler, PhD, Lionel Galicier, MD

Blood (2010) 116 (21): 2869.

https://doi.org/10.1182/blood.V116.21.2869.2869

Published: 2010

NARROW

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Carbapenemase-Producing Enterobacteriaceae (CPE) Bloodstream Infections (BSI) in Neutropenic Patients (pts) with Acute Leukemia (AL). Comparison of 2 Strategies

Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in Dyskeratosis Congenita

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study)

Myeloma Canada Research Network (MCRN)-001 ASCT Study of Busulfan + Melphalan (BuMel) Conditioning Followed By Lenalidomide (Len) Maintenance: Updated Results Including Serial Minimal Residual Disease (MRD) and Involved Serum Hevylite™ Chain (HLC) Ratio Assessments

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities

Extrahematopoietic Manifestations of Telomere Syndromes

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

G6PC3 Deficiency Associated with Congenital Neutropenia and Enterocolitis

Initial Findings From the PACE Trial: A Pivotal Phase 2 Study of Ponatinib in Patients with CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or with the T315I Mutation

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Neutropenia in Glycogen Storage Disease 1b (GSD1b)

Clinical Usefulness of Procalcitonin in Hematopoietic Stem Cell Transplantation

Protective Effect of Rituximab Against Lymphoma Risk In HIV-Associated Multicentric Castleman Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only